Medications

Naloxone access law in Pennsylvania falls short

A new study from researchers at the University of Illinois at Chicago finds that only one-third of pharmacies in Philadelphia carry naloxone nasal spray, a medication used to rapidly counter the effects of opioid overdose, ...

Addiction

Heroin users aware of fentanyl, but at high risk of overdosing

Most heroin users in Baltimore, a city heavily affected by the opioid epidemic, recognize that the heroin they buy is now almost always laced with the highly dangerous synthetic opioid fentanyl, according to a new study led ...

Medications

Converting naloxone to OTC expected to increase sales

(HealthDay)—The demand for naloxone is relatively inelastic with respect to changes in its out-of-pocket price, and conversion to an over-the-counter medication is expected to increase naloxone pharmacy sales, according ...

Medications

Let's talk about Rx use: Recognizing and reversing an overdose

As addiction to opiates continues to be a major public health concern, it has become increasingly important to know how to respond to possible overdose situations. Knowing how to prevent and recognize the signs of an overdose, ...

page 1 from 7

Naloxone

Naloxone is an opioid antagonist drug developed by Sankyo in the 1960s. Naloxone is a drug used to counter the effects of opiate overdose, for example heroin or morphine overdose. Naloxone is specifically used to counteract life-threatening depression of the central nervous system and respiratory system. Naloxone is also experimentally used in the treatment for congenital insensitivity to pain with anhidrosis (CIPA), an extremely rare disorder (1 in 125 million) that renders one unable to feel pain. It is marketed under various trademarks including Narcan, Nalone, and Narcanti, and has sometimes been mistakenly called "naltrexate." It is not to be confused with naltrexone, an opioid receptor antagonist with qualitatively different effects, used for dependence treatment rather than emergency overdose treatment.

This text uses material from Wikipedia, licensed under CC BY-SA